These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 38898747

  • 1. Suitability of frozen cell pellets from cytology specimens for the Amoy 9-in-1 assay in patients with non-small cell lung cancer.
    Kodama H, Murakami H, Mamesaya N, Kobayashi H, Omori S, Wakuda K, Ko R, Ono A, Kenmotsu H, Naito T, Matsumoto S, Goto K, Shimizu T, Gon Y, Takahashi T.
    Thorac Cancer; 2024 Jul; 15(21):1665-1672. PubMed ID: 38898747
    [Abstract] [Full Text] [Related]

  • 2. Comparison between next-generation sequencing and multiplex polymerase chain reaction assays for nonsmall-cell lung cancer molecular diagnosis.
    Murakami S, Shinada K, Otsutsumi Y, Komine F, Yuan Y, Nakamura J, Katakura S, Kondo T, Kato T, Yokose T, Saito H.
    Cancer Med; 2024 Apr; 13(7):e7162. PubMed ID: 38572952
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC, Lai GGY, Tan GS, Poon SY, Doble B, Lim TH, Aung ZW, Takano A, Tan WL, Ang MK, Tan BS, Devanand A, Too CW, Gogna A, Ong BH, Koh TPT, Kanesvaran R, Ng QS, Jain A, Rajasekaran T, Lim AST, Lim WT, Toh CK, Tan EH, Lim TKH, Tan DSW.
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
    Wu W, Cao Z, Zhang W, Zhang L, Hou L, Wu C.
    Diagn Pathol; 2020 Jan 31; 15(1):9. PubMed ID: 32005253
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Genomic Signature of Driver Genes Identified by Target Next-Generation Sequencing in Chinese Non-Small Cell Lung Cancer.
    Wen S, Dai L, Wang L, Wang W, Wu D, Wang K, He Z, Wang A, Chen H, Zhang P, Dong X, Dong YA, Wang K, Yao M, Wang M.
    Oncologist; 2019 Nov 31; 24(11):e1070-e1081. PubMed ID: 30902917
    [Abstract] [Full Text] [Related]

  • 10. Detection and comparison of EGFR mutations from supernatants that contain cell-free DNA and cell pellets from FNA non-small cell lung cancer specimens.
    Wu W, Huang Y, Guo J, Xie X, Li H, Cao Z, Wei H, Wu C.
    Cancer Cytopathol; 2020 Aug 31; 128(8):545-552. PubMed ID: 32286726
    [Abstract] [Full Text] [Related]

  • 11. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
    Sharma S, Satapathy A, Aggarwal A, Dewan A, Jain E, Katara R, Kumar V, Pal R, Pandey S, Naidu MM, Kini L, Pradhan D, Mohanty SK.
    Pathol Res Pract; 2021 Apr 31; 220():153394. PubMed ID: 33706124
    [Abstract] [Full Text] [Related]

  • 12. Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing.
    Mimura C, Takamiya R, Fujimoto S, Fukui T, Yatani A, Yamada J, Takayasu M, Takata N, Sato H, Fukuda K, Furukawa K, Hazama D, Katsurada N, Yamamoto M, Matsumoto S, Goto K, Tachihara M.
    BMC Cancer; 2024 Apr 17; 24(1):489. PubMed ID: 38632507
    [Abstract] [Full Text] [Related]

  • 13. Comprehensive molecular analysis of driver mutations in non-small cell lung carcinomas and its correlation with PD-L1 expression, An Indian perspective.
    Aggarwal A, Sharma S, Brar Z, Kumar V, Kumar A, Katara R, Mohanty SK.
    Pathol Res Pract; 2024 Jan 17; 253():155013. PubMed ID: 38096714
    [Abstract] [Full Text] [Related]

  • 14. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
    Seto K, Masago K, Fujita S, Haneda M, Horio Y, Hida T, Kuroda H, Hosoda W, Okubo KI.
    Thorac Cancer; 2020 Jul 17; 11(7):1827-1834. PubMed ID: 32372482
    [Abstract] [Full Text] [Related]

  • 15. Suitability of transbronchial brushing cytology specimens for next-generation sequencing in peripheral lung cancer.
    Furuya N, Matsumoto S, Kakinuma K, Morikawa K, Inoue T, Saji H, Goto K, Mineshita M.
    Cancer Sci; 2021 Jan 17; 112(1):380-387. PubMed ID: 33124129
    [Abstract] [Full Text] [Related]

  • 16. Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium.
    Li BT, Janku F, Jung B, Hou C, Madwani K, Alden R, Razavi P, Reis-Filho JS, Shen R, Isbell JM, Blocker AW, Eattock N, Gnerre S, Satya RV, Xu H, Zhao C, Hall MP, Hu Y, Sehnert AJ, Brown D, Ladanyi M, Rudin CM, Hunkapiller N, Feeney N, Mills GB, Paweletz CP, Janne PA, Solit DB, Riely GJ, Aravanis A, Oxnard GR.
    Ann Oncol; 2019 Apr 01; 30(4):597-603. PubMed ID: 30891595
    [Abstract] [Full Text] [Related]

  • 17. Comprehensive analysis of NGS and ARMS-PCR for detecting EGFR mutations based on 4467 cases of NSCLC patients.
    He C, Wei C, Wen J, Chen S, Chen L, Wu Y, Shen Y, Bai H, Zhang Y, Chen X, Li X.
    J Cancer Res Clin Oncol; 2022 Feb 01; 148(2):321-330. PubMed ID: 34693477
    [Abstract] [Full Text] [Related]

  • 18. Highly accurate DNA-based detection and treatment results of MET exon 14 skipping mutations in lung cancer.
    Pruis MA, Geurts-Giele WRR, von der TJH, Meijssen IC, Dinjens WNM, Aerts JGJV, Dingemans AMC, Lolkema MP, Paats MS, Dubbink HJ.
    Lung Cancer; 2020 Feb 01; 140():46-54. PubMed ID: 31862577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.